INM Form 10-K: Annual report | INMED PHARMACEUTICALS INC.

INMED PHARMACEUTICALS INC. Form 10-K: Annual report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

2026-09-09: Form 10-K; Period of report 2026-06-30; Description ANNUAL REPORT; Document ea0301263-10k_inmed.htm.
2025-09-23: Form 10-K; Period of report 2025-06-30; Description ANNUAL REPORT; Document ea0253959-10k_inmed.htm.
2024-09-30: Form 10-K; Period of report 2024-06-30; Description ANNUAL REPORT; Document ea0214241-10k_inmed.htm.
2023-09-29: Form 10-K; Period of report 2023-06-30; Description ANNUAL REPORT; Document f10k2023_inmedpharma.htm.

Filed	Form	Period of report	Description	Document
2026-09-09	10-K	2026-06-30	ANNUAL REPORT	ea0301263-10k_inmed.htm
2025-09-23	10-K	2025-06-30	ANNUAL REPORT	ea0253959-10k_inmed.htm
2024-09-30	10-K	2024-06-30	ANNUAL REPORT	ea0214241-10k_inmed.htm
2023-09-29	10-K	2023-06-30	ANNUAL REPORT	f10k2023_inmedpharma.htm
2022-09-23	10-K	2022-06-30	ANNUAL REPORT	f10k2022_inmedpharma.htm
2021-09-24	10-K	2021-06-30	ANNUAL REPORT	f10k2021_inmedpharma.htm

Stock Name	Country	Market Cap	PE Ratio
Apimeds Pharmaceuticals US, Inc. (APUS)	United States	$0.008B
Ensysce Biosciences, Inc. (ENSC)	United States	$0.008B	-0.37
CNS Pharmaceuticals, Inc. (CNSP)	United States	$0.007B
EXICURE, INC. (XCUR)	United States	$0.008B	-1.54
Acurx Pharmaceuticals, Inc. (ACXP)	United States	$0.007B	-0.97
SOLIGENIX, INC. (SNGX)	United States	$0.008B
Imunon, Inc. (IMNN)	United States	$0.008B	-0.56
SYNLOGIC, INC. (SYBX)	United States	$0.007B
Bolt Biotherapeutics, Inc. (BOLT)	United States	$0.007B	-0.26
Enveric Biosciences, Inc. (ENVB)	United States	$0.007B	-0.63